DHG Pharmaceutical JSC (HOSE: DHG)

DHG Pharmaceutical JSC Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	13,074,607	13,597,591	11,100,341	14,774,306	13,597,591	11,963,265
Market Cap Growth	-8.46%	22.50%	-24.87%	8.65%	13.66%	15.82%
Enterprise Value	11,393,367	11,999,699	8,991,684	12,831,532	11,995,781	10,785,078
Last Close Price	100000.00	97445.25	77104.62	99394.43	87908.18	74127.42
PE Ratio	16.26	13.37	11.60	19.75	19.11	19.60
Forward PE	13.01	11.78	11.70	17.65	18.42	18.93
PS Ratio	2.64	2.71	2.37	3.69	3.62	3.07
PB Ratio	2.97	2.80	2.59	3.90	3.81	3.54
P/TBV Ratio	3.31	2.91	2.71	4.12	4.05	3.78
P/FCF Ratio	15.51	-	16.63	34.53	18.44	15.32
P/OCF Ratio	13.97	56.62	12.32	32.65	16.46	14.27
PEG Ratio	4.03	4.03	4.03	4.03	4.03	3.79
EV/Sales Ratio	2.30	2.39	1.92	3.21	3.19	2.77
EV/EBITDA Ratio	11.71	10.53	7.77	13.60	13.37	13.82
EV/EBIT Ratio	13.15	11.40	8.36	14.91	14.82	15.60
EV/FCF Ratio	13.52	-	13.47	29.99	16.27	13.81
Debt / Equity Ratio	0.26	0.12	0.03	0.05	0.06	0.08
Debt / EBITDA Ratio	1.19	0.50	0.10	0.22	0.24	0.34
Debt / FCF Ratio	1.37	-	0.17	0.48	0.29	0.34
Asset Turnover	0.81	0.89	0.96	0.88	0.87	0.93
Inventory Turnover	1.92	1.92	2.08	2.19	2.51	2.70
Quick Ratio	1.90	2.26	3.28	3.18	3.03	3.14
Current Ratio	2.72	3.90	5.20	4.92	4.26	4.45
Return on Equity (ROE)	18.46%	22.98%	24.45%	21.09%	21.27%	19.36%
Return on Assets (ROA)	8.85%	11.66%	13.75%	11.87%	11.77%	10.35%
Return on Capital (ROIC)	9.92%	13.38%	16.00%	13.83%	13.63%	11.77%
Earnings Yield	6.15%	7.73%	8.90%	5.26%	5.44%	5.31%
FCF Yield	6.45%	-1.81%	6.01%	2.90%	5.42%	6.53%
Dividend Yield	7.50%	7.70%	4.54%	3.52%	4.55%	5.40%
Payout Ratio	118.00%	43.55%	46.30%	67.29%	70.69%	51.44%
Total Shareholder Return	7.50%	7.70%	4.54%	3.52%	4.55%	5.40%

Source: S&P Capital IQ. Standard template. Financial Sources.